KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Depreciation & Amortization - Total (2016 - 2025)

Historic Depreciation & Amortization - Total for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $6.3 million.

  • Evolent Health's Depreciation & Amortization - Total fell 1600.0% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.4 million, marking a year-over-year decrease of 1016.39%. This contributed to the annual value of $30.3 million for FY2024, which is 648.15% down from last year.
  • Latest data reveals that Evolent Health reported Depreciation & Amortization - Total of $6.3 million as of Q3 2025, which was down 1600.0% from $6.4 million recorded in Q2 2025.
  • Evolent Health's 5-year Depreciation & Amortization - Total high stood at $8.9 million for Q4 2022, and its period low was $6.3 million during Q3 2025.
  • Over the past 5 years, Evolent Health's median Depreciation & Amortization - Total value was $7.6 million (recorded in 2021), while the average stood at $7.6 million.
  • In the last 5 years, Evolent Health's Depreciation & Amortization - Total skyrocketed by 1470.59% in 2021 and then tumbled by 1898.73% in 2025.
  • Evolent Health's Depreciation & Amortization - Total (Quarter) stood at $7.8 million in 2021, then grew by 14.1% to $8.9 million in 2022, then decreased by 14.61% to $7.6 million in 2023, then fell by 2.63% to $7.4 million in 2024, then fell by 14.86% to $6.3 million in 2025.
  • Its Depreciation & Amortization - Total stands at $6.3 million for Q3 2025, versus $6.4 million for Q2 2025 and $7.3 million for Q1 2025.